| 标题 |
BMS-986458, a first-in-class, bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6) in patients with Relapsed/Refractory (R/R) non-Hodgkin lymphoma (NHL): Updated results from the Phase 1 dose escalation study |
| 网址 | |
| DOI |
10.1182/blood-2025-480
doi
|
| 其它 |
期刊:Blood 作者:Franck Morschhauser; David Qualls; Jennifer Lue; Anastasios Stathis; Marcel Nijland; et al 出版日期:2025-11-03 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)